Tag: Kate Rawson. Jon Bigelow

Kate Rawson. Jon Bigelow

Regulatory/FDA

FDA at Turning Point: Kate Rawson Explains

FDA at Turning Point: Kate Rawson Explains

June 11, 2021 – The Food and Drug Administration (FDA) “is really central, not only to product approvals, but to what [medical product companies] can say in terms of marketing,” according to Prevision Policy Senior Editor Kate Rawson. Rawson, who spoke June 4 at a Coalition for Healthcare Communication (CHC) webinar, “What’s Ahead for the […]

Read more